Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

NCT03856216 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped \<75% participation

Conditions

Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Lymphocytic Neoplasm
Lymphoma

Interventions

PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Bendamustine
BIOLOGICAL: Filgrastim-sndz
DRUG: Fludarabine
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Melphalan
PROCEDURE: Peripheral Blood Stem Cell Transplantation
BIOLOGICAL: Rituximab
DRUG: Tacrolimus

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]